120 related articles for article (PubMed ID: 21714071)
1. ATP13A2 variability in Taiwanese Parkinson's disease.
Chen CM; Lin CH; Juan HF; Hu FJ; Hsiao YC; Chang HY; Chao CY; Chen IC; Lee LC; Wang TW; Chen YT; Chen YT; Lee-Chen GJ; Wu YR
Am J Med Genet B Neuropsychiatr Genet; 2011 Sep; 156B(6):720-9. PubMed ID: 21714071
[TBL] [Abstract][Full Text] [Related]
2. Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore.
Lin CH; Tan EK; Chen ML; Tan LC; Lim HQ; Chen GS; Wu RM
Neurology; 2008 Nov; 71(21):1727-32. PubMed ID: 19015489
[TBL] [Abstract][Full Text] [Related]
3. HTRA2 variations in Taiwanese Parkinson's disease.
Chen CM; Wu CH; Hsieh CH; Lin CH; Chen IC; Chen YC; Lee LC; Lee CM; Tseng YC; Lee-Chen GJ; Wu YR
J Neural Transm (Vienna); 2014 May; 121(5):491-8. PubMed ID: 24337630
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between the ATP13A2 A746T variant and Parkinson's disease susceptibility in Han Chinese: a meta-analysis.
Pan LS; Wang Z; Ding D; Zhu XP; Leng HL; Deng XB; Xu YM
Int J Neurosci; 2016; 126(7):593-9. PubMed ID: 26000924
[TBL] [Abstract][Full Text] [Related]
5. Rapid screening of ATP13A2 variant with high-resolution melting analysis.
Funayama M; Tomiyama H; Wu RM; Ogaki K; Yoshino H; Mizuno Y; Hattori N
Mov Disord; 2010 Oct; 25(14):2434-7. PubMed ID: 20976737
[TBL] [Abstract][Full Text] [Related]
6. ATP13A2 variants in early-onset Parkinson's disease patients and controls.
Djarmati A; Hagenah J; Reetz K; Winkler S; Behrens MI; Pawlack H; Lohmann K; Ramirez A; Tadić V; Brüggemann N; Berg D; Siebner HR; Lang AE; Pramstaller PP; Binkofski F; Kostić VS; Volkmann J; Gasser T; Klein C
Mov Disord; 2009 Oct; 24(14):2104-11. PubMed ID: 19705361
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease.
Dos Santos AV; Pestana CP; Diniz KR; Campos M; Abdalla-Carvalho CB; de Rosso AL; Pereira JS; Nicaretta DH; de Carvalho WL; Dos Santos JM; Santos-Rebouças CB; Pimentel MM
Neurosci Lett; 2010 Nov; 485(2):121-4. PubMed ID: 20816920
[TBL] [Abstract][Full Text] [Related]
8. ATP13A2 variability in Parkinson disease.
Vilariño-Güell C; Soto AI; Lincoln SJ; Ben Yahmed S; Kefi M; Heckman MG; Hulihan MM; Chai H; Diehl NN; Amouri R; Rajput A; Mash DC; Dickson DW; Middleton LT; Gibson RA; Hentati F; Farrer MJ
Hum Mutat; 2009 Mar; 30(3):406-10. PubMed ID: 19085912
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson's disease.
Shen T; Pu J; Lai HY; Xu L; Si X; Yan Y; Jiang Y; Zhang B
Sci Rep; 2018 Sep; 8(1):14028. PubMed ID: 30232368
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 gene in Parkinson's disease patients in Xinjiang Uygur and Han ethnic groups.
Li G; Zhang Z; Xia H; Yang X
Med Sci Monit; 2014 Nov; 20():2177-82. PubMed ID: 25374329
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.
Sato S; Li Y; Hattori N
J Neural Transm (Vienna); 2017 Nov; 124(11):1395-1400. PubMed ID: 28894968
[TBL] [Abstract][Full Text] [Related]
12. Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease.
Rakovic A; Stiller B; Djarmati A; Flaquer A; Freudenberg J; Toliat MR; Linnebank M; Kostic V; Lohmann K; Paus S; Nürnberg P; Kubisch C; Klein C; Wüllner U; Ramirez A
Mov Disord; 2009 Feb; 24(3):429-33. PubMed ID: 19097176
[TBL] [Abstract][Full Text] [Related]
13. ATP13A2 Gene Variants in Patients with Parkinson's Disease in Xinjiang.
Wang D; Gao H; Li Y; Jiang S; Yang X
Biomed Res Int; 2020; 2020():6954820. PubMed ID: 33335927
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia regulation of ATP13A2 (PARK9) gene transcription.
Xu Q; Guo H; Zhang X; Tang B; Cai F; Zhou W; Song W
J Neurochem; 2012 Jul; 122(2):251-9. PubMed ID: 22288903
[TBL] [Abstract][Full Text] [Related]
15. The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
Park JS; Blair NF; Sue CM
Mov Disord; 2015 May; 30(6):770-9. PubMed ID: 25900096
[TBL] [Abstract][Full Text] [Related]
16. The role of the Ala746Thr variant in the ATP13A2 gene among Chinese patients with Parkinson's disease.
Chan AY; Baum L; Tang NL; Lau CY; Ng PW; Hui KF; Mizuno Y; Kwan JY; Mok VC; Kuo SH
J Clin Neurosci; 2013 May; 20(5):761-2. PubMed ID: 23522931
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
Kong SM; Chan BK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA
Hum Mol Genet; 2014 Jun; 23(11):2816-33. PubMed ID: 24603074
[TBL] [Abstract][Full Text] [Related]
18. A lipid switch unlocks Parkinson's disease-associated ATP13A2.
Holemans T; Sørensen DM; van Veen S; Martin S; Hermans D; Kemmer GC; Van den Haute C; Baekelandt V; Günther Pomorski T; Agostinis P; Wuytack F; Palmgren M; Eggermont J; Vangheluwe P
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9040-5. PubMed ID: 26134396
[TBL] [Abstract][Full Text] [Related]
19. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.
Demirsoy S; Martin S; Motamedi S; van Veen S; Holemans T; Van den Haute C; Jordanova A; Baekelandt V; Vangheluwe P; Agostinis P
Hum Mol Genet; 2017 May; 26(9):1656-1669. PubMed ID: 28334751
[TBL] [Abstract][Full Text] [Related]
20. Targeted next-generation sequencing identifies novel variants in candidate genes for Parkinson's disease in Black South African and Nigerian patients.
Oluwole OG; Kuivaniemi H; Abrahams S; Haylett WL; Vorster AA; van Heerden CJ; Kenyon CP; Tabb DL; Fawale MB; Sunmonu TA; Ajose A; Olaogun MO; Rossouw AC; van Hillegondsberg LS; Carr J; Ross OA; Komolafe MA; Tromp G; Bardien S
BMC Med Genet; 2020 Feb; 21(1):23. PubMed ID: 32019516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
